Cyanvac

0 followers

‌

Cyanvac develops vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector.

Industries

Headquarters

Links

Org chart

Chief Executive Officer

Fred C. Davison

Collapse

Chief Financial Officer

Chief Scientific Officer

Chief Regulatory Officer

Chief Business Officer

This company has no teams yet

Illumina

67 followers

Apollo Global Management

36 followers

Exact Sciences

15 followers

Natera

13 followers

Stemline Therapeutics

3 followers

Synthekine

3 followers

Merck

214 followers

Abbott

281 followers

Amplity Health

1 follower

LabConnect

1 follower

Included Health

26 followers

Explore companies